Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia-Reference-Cited by-同舟云学术

Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia

Published:2009-10-19 Issue:1 Volume:332 Page:281-290
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Al-Shamma Hussien A.,Anderson Christen,Chuang Emil,Luthringer Remy,Grottick Andrew J.,Hauser Erin,Morgan Michael,Shanahan William,Teegarden Bradley R.,Thomsen William J.,Behan Dominic

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference37 articles.

1. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs

2. Effect of ritanserin on sleep stages and sleep EEG in the rat

3. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

4. GABAA/Bz Receptor Subtypes as Targets for Selective Drugs

5. Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting Hypnosedatives

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice;Behavioural Brain Research;2024-06

2. Ligand bias and inverse agonism on 5‐HT_2A receptor‐mediated modulation of G protein activity in post‐mortem human brain;British Journal of Pharmacology;2024-04-21

3. The 5‐HT_2A/2C inverse agonist nelotanserin alleviates L‐DOPA‐induced dyskinesia in the MPTP‐lesioned marmoset;European Journal of Neuroscience;2023-07-28

4. An overview of the active clinical trials for Parkinson’s disease psychosis;Neurodegenerative Disease Management;2022-08

5. Alzheimer’s disease and sleep disorders: Insights into the possible disease connections and the potential therapeutic targets;Asian Journal of Psychiatry;2022-02